The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for ...

The drugs most frequently used by these patients were diuretics, converting enzyme inhibitors, calcium channel blockers (CCB), lipid-lowering agents, and salicylates. Eczema was significantly ...

Use of the frequently prescribed L-type dihydropyridine calcium channel blocker amlodipine, which does not effectively cross the blood–brain barrier, did not confer any reduction in PD risk.

Calcium channel blockers are a group of medications that act to inhibit either central or peripheral calcium channels. This results in decreased calcium influx and smooth muscle relaxation.

Magnesium is an essential mineral for the body, but its interaction with certain medications can be harmful. Find out which ...

Calcium channel blocker (CCB) (dihydropyridine). Nifedipine inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. The reduction in calcium influx causes ...

Research has shown that VGCC dysfunction can lead to severe pathologies, highlighting the need for selective calcium channel inhibitors and modulators as potential treatments for these conditions[4].

Calcium channel blocker (CCB) (benzothiazepine). 120 mg: Light turquoise blue/light turquoise blue capsule imprinted with “cardizem CD 120 mg” on body. Supplied in 30- and 90-count bottles.

and treatment with each of three other types of antihypertensive drugs -- a calcium-channel blocker (amlodipine), an angiotensin-converting enzyme inhibitor (lisinopril), and a peripheral a ...

“Our data suggest SGLT2 inhibition as a safe strategy to prevent kidney stone recurrence in patients with kidney stones ,” Dr Fuster’s team concluded. Other study findings indicate the empagliflozin ...

Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost effectiveness of adding a newer anti-anginal drug (nicorandil, ivabradine or ranolazine) to a calcium ...